Andrew Roberts-Achievements

Andrew Roberts-Achievements

Selected achievements

Awards

2016 Johnson & Johnson Eureka Prize for Innovation in Medical Research
2016 Healthcare Innovaton Award - Research, Melbourne Health
2015 Thomoson Reuters Citation Award - Australia
2013 Metcalf Chair of Leukaemia Research, The University of Melbourne
2004 Burnet Prize, Walter and Eliza Hall Institute of Medical Research

Grants and funding 

2017-2021 Specialised Centre of Research, Molecular regulation of blood cell production and function Leukemia and Lymphoma Society (USA)
2017-2021 Program Grant 1016647: Molecular regulation of blood cell production and function, National Health and Medical Research Council 
2014- current Practitioner Fellow, National Health and Medical Research Council
2014-2018 Translational Research Project Grant TRP13041: BH3-mimetics in rational combination therapies to overcome treatment-resistant cancers Victorian Cancer Agency. 
2013-2017 Project Grant 1048312: A placebo-controlled, randomized study to optimize clinical outcomes in patients with FLT3 mutant AML, National Health and Medical Research Council. 

Service to the community 

Chair, Cancer Council Victoria (CCV) Executive Committee (2013-2017)
Director, Australian Leukaemia and Lymphoma Group (ALLG)
Scientific Program Co-Chair, American Society of Hematology (ASH) Annual Scientific Meeting 2015
Member, National Health & Medical Research Council NHMRC Academy 
Member, Australian Government Pharmaceutical Benefits Advisory Committee (PBAC)

Super Content: 

The work that led to the development of a new anti-cancer drug has been awarded the 2016 Johnson & Johnson Eureka Prize for Innovation in Medical Research

Professor Andrew Roberts in the Clinical Translation Centre

Inaugural Metcalf Chair of Leukaemia Research awarded to Professor Andrew Roberts